GENEWIZ and Biomatters announce strategic partnership
South Plainfield, NJ and Auckland, New Zealand – 31 May, 2011 – GENEWIZ, Inc., the number one provider of DNA sequencing services in the United States, and Biomatters, creators of the leading DNA sequence analysis software Geneious Pro, have announced a strategic partnership that will provide an end-to-end solution for DNA sequencing from ordering, through sequencing or synthesis to analysis.
The partnership will mean closer technical integration between the companies’ products and services. Samples sent to GENEWIZ for sequencing will be able to be directly downloaded into Geneious Pro for immediate visualization and analysis, eliminating the need for manual ordering and retrieval, particularly important for large volumes of sequences. Additionally, users will be able to submit in silico designed sequences or oligonucleotides for synthesis directly from Geneious Pro.
GENEWIZ will provide customers with sequence results natively in the .geneious file format in addition to other standard formats. GENEWIZ customers can visualize their data in Geneious, giving them access to professional visualization and analysis tools, as well as best-in-class bioinformatics support for downstream analysis.
“With a common mission to discover innovative scientific solutions, as well as to deliver the highest quality service, I am confident that our partnership with Biomatters will prove advantageous to customers’ research,” stated Dr. Shifang Zhang, Vice President of Corporate Development at GENEWIZ. “The additional analysis tools offered as well as the integration with Geneious will enable customers to further centralize sequencing data for easy access, analysis and management.”
“GENEWIZ is the leader in their field, and by working together we are able to dramatically streamline the workflows of a huge number of researchers. With the large volumes of data scientists must manage these days a saving of minutes per sample soon adds up to a big contribution,” commented Candace Kinser, Biomatters CEO.
“It’s all about making life easier for biologists, so that they can concentrate on the science,” Kinser added. GENEWIZ and Biomatters will also undertake joint marketing and referral campaigns. The two companies have complementary customer bases, with GENEWIZ customers requiring the types of analysis tools available in Geneious Pro and Biomatters customers requiring high-quality low-cost commercial laboratory services.
Biomatters will add GENEWIZ-centric features in a future version of Geneious Pro, including the option to quickly ‘click and download’ sequence results from GENEWIZ’s online CLIMS directly into Geneious Pro, as well as ‘submit for synthesis’ services for gene and oligo synthesis services.
The partnership will mean closer technical integration between the companies’ products and services. Samples sent to GENEWIZ for sequencing will be able to be directly downloaded into Geneious Pro for immediate visualization and analysis, eliminating the need for manual ordering and retrieval, particularly important for large volumes of sequences. Additionally, users will be able to submit in silico designed sequences or oligonucleotides for synthesis directly from Geneious Pro.
GENEWIZ will provide customers with sequence results natively in the .geneious file format in addition to other standard formats. GENEWIZ customers can visualize their data in Geneious, giving them access to professional visualization and analysis tools, as well as best-in-class bioinformatics support for downstream analysis.
“With a common mission to discover innovative scientific solutions, as well as to deliver the highest quality service, I am confident that our partnership with Biomatters will prove advantageous to customers’ research,” stated Dr. Shifang Zhang, Vice President of Corporate Development at GENEWIZ. “The additional analysis tools offered as well as the integration with Geneious will enable customers to further centralize sequencing data for easy access, analysis and management.”
“GENEWIZ is the leader in their field, and by working together we are able to dramatically streamline the workflows of a huge number of researchers. With the large volumes of data scientists must manage these days a saving of minutes per sample soon adds up to a big contribution,” commented Candace Kinser, Biomatters CEO.
“It’s all about making life easier for biologists, so that they can concentrate on the science,” Kinser added. GENEWIZ and Biomatters will also undertake joint marketing and referral campaigns. The two companies have complementary customer bases, with GENEWIZ customers requiring the types of analysis tools available in Geneious Pro and Biomatters customers requiring high-quality low-cost commercial laboratory services.
Biomatters will add GENEWIZ-centric features in a future version of Geneious Pro, including the option to quickly ‘click and download’ sequence results from GENEWIZ’s online CLIMS directly into Geneious Pro, as well as ‘submit for synthesis’ services for gene and oligo synthesis services.